Quest Diagnostics (DGX) Net Cash Flow (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Net Cash Flow data on file, last reported at -$26.0 million in Q1 2026.

• Quarterly Net Cash Flow rose 92.82% year-over-year to -$26.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $203.0 million (up 172.5% YoY) and the FY2025 annual result came in at -$133.0 million, down 2.31% from the prior year.
• Net Cash Flow slipped to -$26.0 million in Q1 2026 per DGX's latest filing, from -$13.0 million in the prior quarter.
• The five-year high for Net Cash Flow was $543.0 million in Q4 2023, with the low at -$385.0 million in Q4 2022.
• Average Net Cash Flow over 5 years is -$27.9 million, with a median of -$49.0 million recorded in 2023.
• Year-over-year, Net Cash Flow sank 322.22% in 2022 and surged 2800.0% in 2024.
• Quest Diagnostics' Net Cash Flow stood at -$385.0 million in 2022, then surged by 241.04% to $543.0 million in 2023, then sank by 138.31% to -$208.0 million in 2024, then jumped by 93.75% to -$13.0 million in 2025, then slumped by 100.0% to -$26.0 million in 2026.
• Business Quant data shows DGX's Net Cash Flow at -$26.0 million in Q1 2026, -$13.0 million in Q4 2025, and $115.0 million in Q3 2025.